Inventor · disambiguated record
Tao Xin
Also filed as: XIN TAO
28 granted patents·46 pending applications·419 citations·filing 1998–2025
97Inventor score
Top patents by PatentIndex Score
74 records- 0196US7112595B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2003·Granted Sep 26, 2006·92 cites·23 claims
- 0289US6686374B1Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2000·Granted Feb 3, 2004·24 cites·10 claims
- 0387US7960422B2Pharmaceutically active compounds containing tetrazolyl and triazolyl ringsASTRAZENECA AB·Filed 2008·Granted Jun 14, 2011·11 cites·2 claims
- 0486US6133287APiperidine-indole compounds having 5-HT6 affinityALLELIX BIOPHARMA·Filed 1998·Granted Oct 17, 2000·38 cites·19 claims
- 0585US7476684B2Compounds for the treatment of neurological, psychiatric or pain disordersASTRAZENECA AB·Filed 2006·Granted Jan 13, 2009·11 cites·5 claims
- 0685US7268127B2Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2005·Granted Sep 11, 2007·5 cites·7 claims
- 0783US7074809B2CompoundsNPS PHARMA INC·Filed 2003·Granted Jul 11, 2006·23 cites·12 claims
- 0883US6916818B2Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2003·Granted Jul 12, 2005·12 cites·5 claims
- 0983US6635639B2Use of N-alkylamino-heterocylic compounds for the treatment of migraineNPS ALLELIX CORP·Filed 2002·Granted Oct 21, 2003·20 cites·15 claims
- 1083US6251893B1Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinityNPS ALLELIX CORP·Filed 1998·Granted Jun 26, 2001·68 cites·30 claims
- 1182US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 1281US6897215B1Compounds having 5-HT6 receptor antagonist activityNPS ALLELIX CORP·Filed 2000·Granted May 24, 2005·11 cites·23 claims
- 1378US6100291APyrrolidine-indole compounds having 5-HT6 affinityALLELIX BIOPHARMA·Filed 1998·Granted Aug 8, 2000·23 cites·23 claims
- 1476US12042478B2(R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereofPHARMALA BIOTECH INC·Filed 2023·Granted Jul 23, 2024·0 cites·6 claims
- 1576US6716837B1Heterocyclic compounds for the treatment of migraineNPS ALLELIX BIOPHARMACEUTICALS·Filed 2000·Granted Apr 6, 2004·13 cites·20 claims
- 1675US7772235B2mGluR5 modulatorsASTRAZENECA AB·Filed 2007·Granted Aug 10, 2010·2 cites·6 claims
- 1774US8148394B2Azaindoles having serotonin receptor affinityEDWARDS LOUISE·Filed 2007·Granted Apr 3, 2012·2 cites·16 claims
- 1874US7678796B2MGluR5 modulators IASTRAZENECA AB·Filed 2007·Granted Mar 16, 2010·3 cites·21 claims
- 1972US7576077B2Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 2071US2024325338A1(r)-2-[(2h-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereofPHARMALA BIOTECH INC·Filed 2024·Application pending·0 cites
- 2168US6191141B1Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 1999·Granted Feb 20, 2001·26 cites·8 claims
- 2265US5914401AMethods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereofAPOTEX INC·Filed 1998·Granted Jun 22, 1999·11 cites·16 claims
- 2362US2007293545A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2462US2008015204A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2562US2008045571A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2662US2008015234A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2762US2025154140A1Isoquinoline derivatives as inhibitors of bax and/or bak, compositions and uses thereofSUNNYBROOK RES INST·Filed 2023·Application pending·0 cites
- 2861US2025170092A1(r)-2-[(2h-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereofPHARMALA BIOTECH INC·Filed 2025·Application pending·0 cites
- 2958US9938240B2Fluorinated derivatives of 3-hydroxypyridin-4-onesAPOTEX TECH INC·Filed 2016·Granted Apr 10, 2018·0 cites·11 claims
- 3057US2007179188A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 3156US6380242B1N-alkylamino-indoles for the treatment of migraineNPS ALLELIX CORP·Filed 1999·Granted Apr 30, 2002·11 cites·8 claims
- 3256US2024343704A1Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 3355US2024270710A1Processes for the preparation of the enantiomers of 3,4-methylenedioxymethamphetamine (mdma) and n-methyl-1,3-benzodioxolylbutanamine (mbdb)PHARMALA BIOTECH INC·Filed 2022·Application pending·0 cites
- 3455US2024425479A1Halo-substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 3554US2024317723A1Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 3654US2017247329A1"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones"APOTEX TECH INC·Filed 2017·Application pending·0 cites
- 3753US9073865B2Fluorinated derivates of 3-hydroxypyridin-4-onesTAM TIM FAT·Filed 2010·Granted Jul 7, 2015·0 cites·46 claims
- 3853US2012302596A1Azaindoles having serotonin receptor affinityEDWARDS LOUISE·Filed 2012·Application pending·0 cites
- 3953US2007270469A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 4053US2007270468A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 4152US2008312246A1Substituted Piperazines as Metabotropic Glutamate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4252US2008312240A1Bicyclic Piperazines as Metabotropic Glutatmate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4352US2007037816A1Bicyclic piperazines as metabotropic glutatmate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 4451US9550733B2Fluorinated derivatives of 3-hydroxypyridin-4-onesAPOTEX TECH INC·Filed 2015·Granted Jan 24, 2017·0 cites·12 claims
- 4549US7691892B2Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Apr 6, 2010·0 cites·22 claims
- 4649US2016083346A1Fluorinated Derivatives of 3-Hydroxypyridin-4-OnesAPOTEX TECHNOLOGIES INC·Filed 2015·Application pending·0 cites
- 4748US2006019997A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 4848US2007185178A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 4948US2006063772A1New compoundsARORA JALAJ·Filed 2005·Application pending·0 cites
- 5048US2007049578A1Cinnamamide compounds as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tao Xin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →